05:39 PM EDT, 05/28/2024 (MT Newswires) -- Anika Therapeutics ( ANIK ) said Tuesday its board approved a $40 million share repurchase program.

The company said $15 million will be effected through the 10b5-1 plan before June 30, 2025, and the remaining $25 million will be purchased in the open market before June 30, 2026.

The share repurchase program replaces the existing buyback approval, Anika Therapeutics ( ANIK ) added.

Price: 25.24, Change: +0.48, Percent Change: +1.94